HealthTree for Lymphoma

HealthTree for Lymphoma HealthTree is using innovation to save lives.

We empower people with CLL through tools that help them live longer and better as they become active contributors to lifesaving research.

This World Blood Cancer Day, we invite you to Be the reason 💜More than 192,000 people are expected to be diagnosed with ...
05/28/2026

This World Blood Cancer Day, we invite you to Be the reason 💜
More than 192,000 people are expected to be diagnosed with a blood cancer this year in the U.S. That’s someone every 3 minutes.
BE:
The reason patients find answers
The reason they feel supported
The reason they can take an active role in their care
At HealthTree Foundation, we provide education, community, and tools that support informed decision-making.
💛 Help raise awareness and support others
👉 Download and share the awareness toolkit: https://healthtree.org/myeloma/community/world-blood-cancer-day

05/27/2026

"We can own the pace of our own cure if we participate in research."
This Cancer Research Month, we invite you to be part of something that has never been done before.
At HealthTree, we turn scattered records into clean, trusted insights to accelerate blood cancer discoveries. Every survey you take, every record you share, and every experience you tell us about help bridge gaps in research to optimize care and personalize treatments.
If you want to learn more about how to participate in research, email [email protected] or call 800-709-1113, and our patient navigators can guide you on the best way to get started.

Mental Health Awareness Month, JOIN US👇Help someone today
05/23/2026

Mental Health Awareness Month, JOIN US
👇
Help someone today

Many people are starting to rethink how much red meat they eat and for good reason 🥩Research shows that high consumption...
05/22/2026

Many people are starting to rethink how much red meat they eat and for good reason 🥩
Research shows that high consumption of red and processed meats may be linked to an increased risk of certain cancers, particularly when consumed frequently over time. Factors like processing, cooking at high temperatures, and inflammation may all play a role.
The good news is that you don’t need to make extreme changes. Small shifts like choosing poultry or fish more often, limiting processed meats, and adjusting cooking methods can support your long-term health.
At HealthTree Foundation, we share research-backed insights to help you feel more confident in your health decisions.
👉 Read the full article here: https://healthtree.org/myeloma/community/articles/26-red-meat-and-cancer-risk?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

05/21/2026

Mental health is an essential part of cancer care 💚
As part of Mental Health Awareness Month, we are sharing key takeaways from our recent webinar with Dr. Meagan Dwyer on coping with the emotional challenges that can come with cancer.
From managing anxiety and stress to recognizing when it may be time to seek extra support, this conversation offered practical tools and compassionate guidance for both patients and caregivers.
One important reminder: what you are feeling is valid, common, and you do not have to go through it alone.
Watch the full webinar here: https://healthtree.org/blood-cancer/community/events/may26-mental-health-tools-blood-cancer?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

On International Clinical Trial Day, we’re debunking the myths. Clinical trials provide access to tomorrow’s treatments,...
05/20/2026

On International Clinical Trial Day, we’re debunking the myths. Clinical trials provide access to tomorrow’s treatments, giving doctors the insights needed to fight cancer more effectively. Clinical research is the engine driving medical progress.
By joining a trial, you gain:
Early access to cutting-edge therapies.
Expert care from top-tier specialists.
A legacy of hope for future generations.
Check out HealthTree’s Clinical Trial Finder here to learn more: https://healthtree.org/blood-cancer/curehub/private/clinical-trials?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

Sleep is a critical part of healing but it’s often overlooked in cancer care 😴Research shows that sleep supports immune ...
05/15/2026

Sleep is a critical part of healing but it’s often overlooked in cancer care 😴
Research shows that sleep supports immune function, tissue repair, and emotional well being. Yet many patients experience sleep problems during and after treatment.
Poor sleep can worsen fatigue, pain, and mood making it harder to recover and feel your best.
Understanding the role of sleep is an important step in improving your overall health.
At HealthTree Foundation, we’re sharing research backed insights to support patients through every stage of care.
👉 Read more here: https://healthtree.org/blood-cancer/community/articles/26-find-better-sleep-with-cancer?utm_source=&utm_medium=meta&utm_campaign=socialmediaorganic&utm_content=general

On May 13, 2026, the U.S. Food and Drug Administration (FDA) approved sonrotoclax (Beqalzi, BeOne Medicines) for adults ...
05/14/2026

On May 13, 2026, the U.S. Food and Drug Administration (FDA) approved sonrotoclax (Beqalzi, BeOne Medicines) for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two prior treatments, including a BTK inhibitor.

MCL is a rare and often aggressive type of non-Hodgkin lymphoma. About 3,300 people in the United States are diagnosed with MCL each year. While many people respond to first treatments, the lymphoma often returns over time. Outcomes can become more difficult after treatment, especially after a BTK inhibitor.

Sonrotoclax is a next-generation BCL-2 inhibitor. Researchers designed it to be more selective and potent than earlier medicines in this drug class. This means it may target lymphoma cells more precisely, affect fewer healthy cells, and work more strongly against cancer cells.

The approval of sonrotoclax gives people with relapsed or refractory MCL a new targeted treatment option. It is also the first BCL-2 inhibitor approved for MCL and the first new BCL-2 inhibitor approved in the United States in about 10 years.

Full article here: https://healthtree.org/mantle-cell-lymphoma/community/articles/26-fda-approves-sonrotoclax-beqalzi-mcl?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

Cancer Research Month honors the science, patients, and clinical trials behind every survival milestone.At HealthTree, p...
05/14/2026

Cancer Research Month honors the science, patients, and clinical trials behind every survival milestone.
At HealthTree, patient-powered research is advancing the field in areas such as MRD, pain management, CAR-T, and emerging therapies like talquetamab.
Every survey, every study, and every shared experience helps accelerate care, improve lives, and bring us closer to cures.
Join the research → https://healthtree.org/curehub

Mental health challenges during cancer are more common than many people realize.This Mental Health Awareness Month, we’r...
05/12/2026

Mental health challenges during cancer are more common than many people realize.
This Mental Health Awareness Month, we’re sharing resources to help patients better understand the role mental health support can play in overall care.
Our latest article, How Mental Health Medications Are Used in Cancer Care, explores how medications, therapy, mindfulness practices, and integrative approaches may support emotional well-being during diagnosis and treatment.
👉 Read more here: https://healthtree.org/myeloma/community/articles/26-medications-for-mental-health-in-cancer?utm_source=&utm_medium=meta&utm_campaign=socialmediaorganic&utm_content=general

Address

10897 S River Front Pkwy
Lehi, UT
84095

Telephone

+18007091113

Website

Alerts

Be the first to know and let us send you an email when HealthTree for Lymphoma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to HealthTree for Lymphoma:

Shortcuts

Share

Category